1. Home
  2. |Insights
  3. |Legal Strategies for Developing Generic Medicines

Legal Strategies for Developing Generic Medicines

Event | 07.10.06 - 07.11.06, 12:00 AM UTC - 12:00 AM UTC

Hear practical and in-depth presentations on:

  • The new European Pharmaceutical legislation
  • The Bolar Provision and disparities between EU Member States
  • Patent litigation: a year in review
  • Patent considerations before a generic drug launch
  • Authorised generics and how to steal a march on your competitors
  • The legal and regulatory landscape for biosimilars in the EU
  • Formulation patents
  • Evergreening policy of originators and possible counter-measures of the generic side

Crowell & Moring's Kristof Roox will be participating in a panel discussion, The Legal and Regulatory Framework for Biosimilar Products in the EU. His discussion will address the need for a different abridged regime; the regime essentials; the new guidelines (quality, non-clinical and clinical issues/specific products); Omnitrope and Valtropin and implications.

Insights

Event | 02.20.25

Has the Buss Stopped? Recoupment Today

Has the Buss Stopped? Recoupment Today: In 1997, the California Supreme Court decided Buss v. Superior Court. In Buss, the court concluded that a liability insurer that defended a mixed action could seek reimbursement from the insured for the defense costs associated with the claims that were not even potentially covered. Since then, numerous courts have held that insurers are entitled to recoup their defense costs associated with uncovered claims or causes of action. On the other hand, a significant number of courts have rejected insurers’ right to recoupment, at least in the absence of a policy provision granting the insurer that right. Some commentators have even suggested that the current judicial trend might be away from permitting insurers to recoup their defense costs. Is that correct? Has the Buss stopped? This panel of coverage experts will analyze insurers’ claimed right to recoupment today, and offer their perspectives on what the law on recoupment should perhaps be and might be in the future.